Altered insulin-induced relaxation of aortic rings in a dihydrotestosterone-induced rodent model of polycystic ovary syndrome

Fertility and Sterility

Volumn 99, Issue 2, 2013, Pages 573-578

  Masszi, Gabriella ^a   Buday, Anna ^b   Novak, Agnes ^b   Horvath, Eszter Maria ^b   Tarszabo, Robert ^b   Sara, Levente ^b   Revesz, Csaba ^b   Benko, Rita ^b   Nadasy, Gyorgy L ^b   Benyó, Zoltán ^b   Hamar, Peter ^b   Varbiro, Szabolcs ^b  

^a BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

dihydrotestosterone; PCOS; Rat; vascular insulin resistance; vitamin D

Indexed keywords

ANDROSTANOLONE; FRUCTOSAMINE; GLUCOSE; INSULIN; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTANOID; VITAMIN D;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FRUCTOSAMINE BLOOD LEVEL; INSULIN RESISTANCE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR RESISTANCE; VASCULAR RING; VASOCONSTRICTION; VASODILATATION;

ANIMALS; AORTA; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; RATS; RATS, WISTAR; VASODILATION; VITAMIN D;

EID: 84873321144     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.09.024     Document Type: Article

References (28)

1. S. Sukalich, and D. Guzick Cardiovascular health in women with polycystic ovary syndrome Semin Reprod Med 21 2003 309 315
2. A. Dokras Cardiovascular disease risk factors in polycystic ovary syndrome Semin Reprod Med 26 2008 39 44
3. L. Mannerås, S. Cajander, A. Holmang, Z. Seleskovic, T. Lystig, and M. Lönn A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome Endocrinology 148 2007 3781 3791
4. L.L. Yanes, D.G. Romero, M. Moulana, R. Lima, D.D. Davis, and H. Zhang Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome Gend Med 8 2011 103 115
5. S.E. Karakas, K. Kim, and A.J. Duleba Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndrome Diabetes Care 33 2010 887 893
6. N. Agarwal, S.P. Rice, H. Bolusani, S.D. Luzio, G. Dunseath, and M. Ludgate Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial J Clin Endocrinol Metab 95 2010 722 730
7. S. Palomba, A. Falbo, F. Giallauria, T. Russo, A. Tolino, and F. Zullo Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome Diabetes Care 33 2010 246 251
8. K.K. Naka, S.N. Kalantaridou, M. Kravariti, A. Bechlioulis, N. Kazakos, and K.A. Calis Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study Fertil Steril 95 2011 203 209
9. S. Thys-Jacobs, D. Donovan, A. Papadopoulos, P. Sarrel, and J.P. Bilezikian Vitamin D and calcium dysregulation in the polycystic ovarian syndrome Steroids 64 1999 430 435
10. Y.F. Yiu, Y.H. Chan, K.H. Yiu, C.W. Siu, S.W. Li, and L.Y. Wong Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes J Clin Endocrinol Metab 96 2011 E830 E835
11. K. Kotsa, M.P. Yavropoulou, O. Anastasiou, and J.G. Yovos Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome Fertil Steril 92 2009 1053 1058
12. M.S. Wong, R. Delansorne, R.Y. Man, P. Svenningsen, and P.M. Vanhoutte Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat Am J Physiol Heart Circ Physiol 299 2010 H1226 H1234
13. R. Przybylski, S. Mccune, B. Hollis, and R.U. Simpson Vitamin D deficiency in the spontaneously hypertensive heart failure (SHHF) prone rat Nutr Metab Cardiovasc Dis 20 2010 641 646
14. L. Sara, P. Antal, G. Masszi, A. Buday, E.M. Horvath, and P. Hamar Arteriolar insulin resistance in a rat model of polycystic ovary syndrome Fertil Steril 97 2012 462 468
15. B. Horvath, P. Orsy, and Z. Benyó Endothelial NOS-mediated relaxations of isolated thoracic aorta of the C57BL/6J mouse: a methodological study J Cardiovasc Pharmacol 45 2005 225 231
16. A. Buday, P. Orsy, M. Godó, M. Mózes, G. Kökény, and Z. Lacza Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice Am J Physiol Heart Circ Physiol 299 2010 H386 H395
17. I.H. Schulman, M.S. Zhou, E.A. Jaimes, and L. Raij Dissociation between metabolic and vascular insulinresistance in aging Am J Physiol Heart Circ Physiol 293 2007 H853 H859
18. J.A. Kim, H.J. Jang, L.A. Martinez-Lemus, and J.R. Sowers Activation of mTOR/p70S6 Kinase by ANG II Inhibits InsulinStimulated Endothelial Nitric Oxide Synthase and Vasodilation Am J Physiol Endocrinol Metab 302 2012 E201 E208
19. A. Dellipizzi, M.L. Pucci, A.Y. Mosny, K. Deseyn, and A. Nasjletti Contribution of constrictor prostanoids to the calcium-dependent basal tone in the aorta from rats with aortic coarctation-induced hypertension: relationship to nitric oxide JPET 283 1997 75 81
20. J. Keller, M. Mandala, P. Casson, and G. Osol Endothelial dysfunction in a rat model of PCOS: evidence of increased vasoconstrictor prostanoid activity Endocrinology 152 2011 4927 4936
21. L. Luksha, S. Agewall, and K. Kublickiene Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease Atherosclerosis 202 2009 330 344
22. D.T. Ngo, W.P. Chan, S. Rajendran, T. Heresztyn, A. Amarasekera, and A.L. Sverdlov Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D Nitric Oxide 25 2011 326 330
23. 3 treatment on glucose metabolism and menstrual frequency in PCOS women - a pilot study J Endocrinol Invest 34 2011 757 763
24. C.K. Glass, and J.M. Olefsky Inflammation and lipid signaling in the etiology of insulin resistance Cell Metab 15 2012 635 645
25. Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N, et al. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev. In press. doi:10.1210/er.2012-1003.
26. C.J. Malkin, R.D. Jones, T.H. Jones, and K.S. Channer Effect of testosterone on ex vivo vascular reactivity in man Clin Sci (Lond) 111 2006 265 274
27. R.J. Gonzales, A.A. Ghaffari, S.P. Duckles, and D.N. Krause Testosterone treatment increases thromboxane function in rat cerebral arteries Am J Physiol Heart Circ Physiol 289 2005 H578 H585
28. C. Meyer, B.P. McGrath, and H.J. Teede Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome Diabetes Care 30 2007 471 478